Alice Boilève

2.0k total citations · 1 hit paper
68 papers, 756 citations indexed

About

Alice Boilève is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alice Boilève has authored 68 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 26 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alice Boilève's work include Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Cancer Genomics and Diagnostics (12 papers). Alice Boilève is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Cancer Genomics and Diagnostics (12 papers). Alice Boilève collaborates with scholars based in France, United States and Italy. Alice Boilève's co-authors include Gabriel G. Malouf, Guillaume Beinse, Ronan Flippot, Michel Ducreux, Valérie Boige, Marc Hilmi, Antoine Hollebecque, David Malka, Matthieu Delaye and Cindy Neuzillet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Alice Boilève

59 papers receiving 749 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial

2024 57 citations Valérie Boige, Alice Boilève et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alice Boilève France	16	409	283	214	207	192	68	756
Niels Henrik Holländer Denmark	13	481 1.2×	157 0.6×	383 1.8×	314 1.5×	119 0.6×	44	838
Suebpong Tanasanvimon Thailand	10	285 0.7×	257 0.9×	67 0.3×	160 0.8×	128 0.7×	34	536
Chao Cai China	17	176 0.4×	136 0.5×	135 0.6×	261 1.3×	265 1.4×	48	768
Yunfei Wang United States	16	413 1.0×	111 0.4×	155 0.7×	190 0.9×	186 1.0×	51	761
Zhaoxu Zheng China	14	518 1.3×	252 0.9×	156 0.7×	199 1.0×	236 1.2×	52	799
Ryu Shimada Japan	15	396 1.0×	206 0.7×	289 1.4×	281 1.4×	141 0.7×	48	811
Seung‐Hoon Beom South Korea	17	459 1.1×	230 0.8×	110 0.5×	150 0.7×	361 1.9×	69	901
Seyoung Seo South Korea	15	369 0.9×	84 0.3×	112 0.5×	217 1.0×	294 1.5×	46	676
Virginia Arrazubi Spain	12	372 0.9×	155 0.5×	109 0.5×	136 0.7×	235 1.2×	48	641
Laurence P. Diggs United States	14	391 1.0×	192 0.7×	131 0.6×	185 0.9×	173 0.9×	37	823

Countries citing papers authored by Alice Boilève

Since Specialization

Citations

This map shows the geographic impact of Alice Boilève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Boilève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Boilève more than expected).

Fields of papers citing papers by Alice Boilève

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Boilève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Boilève. The network helps show where Alice Boilève may publish in the future.

Co-authorship network of co-authors of Alice Boilève

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Boilève. A scholar is included among the top collaborators of Alice Boilève based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Boilève. Alice Boilève is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dusetti, Nelson, Jean‐Baptiste Bachet, Brice Chanez, et al.. (2025). Medical management of pancreatic cancer: from personalization to broadening treatment strategies. Cancer Treatment Reviews. 138. 102973–102973. 2 indexed citations

Farhat, Rayan, Jérôme Cartry, Jacques R.R. Mathieu, et al.. (2025). The pro-apoptotic peptide PEP-010 triggers apoptosis in pancreatic tumor models in monotherapy and in combination with gemcitabine independently of the KRAS status. Cancer Letters. 630. 217896–217896.

Taı̈eb, Julien, Margherita Ambrosini, Sara Lonardi, et al.. (2025). Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 13(1). e010424–e010424. 2 indexed citations

Smolenschi, Cristina, et al.. (2025). Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers. European Journal of Cancer. 222. 115432–115432. 2 indexed citations

Boilève, Alice, Cristina Smolenschi, Aurélien Lambert, et al.. (2024). KRAS, a New Target for Precision Medicine in Colorectal Cancer?. Cancers. 16(20). 3455–3455. 6 indexed citations

Faron, Matthieu, Frédèric Deschamps, Adrian Kobe, et al.. (2024). Safety and efficacy of percutaneous arterial port Implantation for Hepatic Arterial Infusion Chemotherapy. European Radiology. 35(2). 1022–1033. 2 indexed citations

Nicolle, Rémy, Valérie Boige, T. Pudlarz, et al.. (2023). Precision medicine for KRAS wild-type pancreatic adenocarcinomas. European Journal of Cancer. 197. 113497–113497. 16 indexed citations

Smolenschi, Cristina, Antoine Hollebecque, Alice Boilève, et al.. (2023). PD-29 Could molecular profiling be helpful in daily practice in the treatment of anal carcinoma?. Annals of Oncology. 34. S13–S13. 1 indexed citations

Rémond, Marc, Antoine Hollebecque, Maximiliano Gelli, et al.. (2023). 1667P Clinical and molecular features of young onset pancreatic adenocarcinoma. Annals of Oncology. 34. S917–S917. 1 indexed citations

10.

Edeline, Julien, Julie Henriques, Héloïse Bourien, et al.. (2023). 119P Management of biliary tract cancers in older patients: A French multicenter cohort study. Annals of Oncology. 34. S226–S227. 1 indexed citations

11.

Boilève, Alice, Matthieu Faron, Arnaud Bayle, et al.. (2023). Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. European Journal of Cancer. 186. 122–132. 7 indexed citations

12.

Boilève, Alice, Étienne Rouleau, Raymond E. Eid, et al.. (2023). SO-4 Impact of molecular profiling on survival in patients with advanced biliary tract cancers. Annals of Oncology. 34. S163–S163. 2 indexed citations

13.

Pilla, Lorenzo, Kathrin Heinrich, Volker Kunzmann, et al.. (2023). Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.. Journal of Clinical Oncology. 41(16_suppl). 4148–4148.

14.

Bonnet‐Lebrun, Anne‐Sophie, Alice Boilève, Alexandre Debrumetz, et al.. (2022). A Pilot Study on the Association Between Early Fluid Status Indicators After Kidney Transplantation and Graft Function Recovery. Kidney International Reports. 7(6). 1416–1419. 1 indexed citations

15.

Bonnet‐Lebrun, Anne‐Sophie, Alice Boilève, Julien Charpentier, et al.. (2022). Impact of early mean arterial pressure level on severe acute kidney injury occurrence after out-of-hospital cardiac arrest. Annals of Intensive Care. 12(1). 69–69. 9 indexed citations

16.

Boilève, Alice, Aline Maillard, Mathilde Wagner, et al.. (2020). Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol. BMC Cancer. 20(1). 74–74. 12 indexed citations

17.

Boilève, Alice, Armelle Dufresne, Ali N. Chamseddine, et al.. (2020). Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment. ESMO Open. 5(6). e001082–e001082. 2 indexed citations

18.

Hilmi, Marc, et al.. (2020). Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey. Clinical Cancer Research. 26(18). 1 indexed citations

19.

Hollebecque, Antoine, Lambros Tselikas, Michel Ducreux, et al.. (2020). 70P Genomic landscape and efficacy of precision medicine in biliary tract cancers. Annals of Oncology. 31. S267–S268. 2 indexed citations

20.

Flippot, Ronan, et al.. (2019). Long non-coding RNAs in genitourinary malignancies: a whole new world. Nature Reviews Urology. 16(8). 484–504. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact